Generics 12

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Parecoxib sodium manufacturers

12 products found

Filters

12 products found

parecoxib sodium

Powder and solvent for solution for infusion 40 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply, Distribution only
Comments
Dossier availability date: Q4 2023
Manufacturer #1377
A pharmaceutical manufacturer based in the EU that has been active in 40+ countries selling its products in Europe, the Middle East, North America, Africa, and Asia for 200+ years. Key production lines are Rx, OTC, nutraceuticals, and medical devices. The company's production lines are GMP-compliant. Main dosage forms include solids, liquids, semi-solids, and sterile forms.

Manufacturer usually replies in 8 days

parecoxib sodium

Injection, lyophilized 40 mg - 2 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, GR
Unavailable markets
Kosovo , Vietnam , Austria , Belgium , Bulgaria , Croatia , Cyprus , Czech Republic , Denmark , Estonia , Finland , France , Germany , Greece , Hungary , Iceland , Italy , Ireland , Latvia , Lithuania , Malta , Netherlands , Norway , Poland , Portugal , Romania , Slovakia , Spain , Sweden , United Kingdom
Manufacturer #298

Manufacturer usually replies in 5 days

parecoxib sodium

Solution for injection 20 mg, 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
TGA, China
Unavailable markets
Australia , South Africa , Thailand
Manufacturer #12677

Manufacturer usually replies in 4 days

Want to see all 12 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

PARECOXIB SODIUM

Parecoxib Sodium is water-soluble, injectable sodium salt form of Parecoxib, an amide prodrug of the cyclooxygenase II selective, non-steroidal anti-inflammatory drug (NSAID) Valdecoxib, with anti- inflammatory, analgesic, and antipyretic properties. After entering the body, Parecoxib is hydrolyzed by hepatic carboxyesterases to its active form, valdecoxib to binds to and inhibits COX-2. These actions of Parecoxib Sodium prevents the conversion of arachidonic acid into prostaglandins, which are responsible for the regulation of pain, inflammation, and fever. Parecoxib Sodium does not inhibit COX-1 at therapeutic concentrations and thus does not interfere with blood coagulation. Parecoxib, sold under the brand name Dynastat among others Monsanto led by John Talley discovered Parecoxib, along with other COX-2 selective inhibitors, celecoxib, valdecoxib, and mavacoxib. Parecoxib was patented in 1996 and approved for medical use in 2002. However, In 2005, the U.S. Food and Drug Administration issued a letter of non-approval for parecoxib in the United States. No reasons were given for the non approval.

Forms and Dosage

Each Powder vial of Parecoxib contains 40 mg Parecoxib and After reconstitution, the concentration of Parecoxib is 20 mg/ml. Every 2 ml of reconstituted powder contains 40 mg of parecoxib. The normal recommended adult dose is a single 40 mg dose administered intravenously or intramuscularly. However, for elder patients weighing less than 50 kgs, the prescribed dosage is 20 mg only.

The cost Parecoxib Sodium

When bought in its chemical form PS costs between 5000 and 16,000 USD per kilo. Whereas the tablets, whereas the 100 mg vial costs USD 240.

How does it work?

PS belongs to a group of medicines called coxibs. Their main action is relieving pain and inflammation. Following injection, parecoxib sodium is rapidly converted to valdecoxib which inhibits cyclooxygenase-2 mediated prostaglandin synthesis. In the process, Valdecoxib reduces the production of prostaglandins needed as mediators of pain and inflammation. If administered at recommended doses in acute pain management, the onset of analgesia was 7–14 minutes and reached a peak effect within 2 hours.

Finding Parecoxib Sodium Manufacturers and Parecoxib Sodium Suppliers

One of the fastest and easiest ways to find Parecoxib Sodium manufacturers and Parecoxib Sodium suppliers is to make use of Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Usually, finding trusted manufacturers and supplies of specific drugs like Parecoxib Sodium can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is make use of our integrated search engine and start looking for suppliers or manufacturers of Parecoxib Sodium to work with. You can fine-tune your search results using various filters too, letting you search for Parecoxib Sodium from specific countries, for example.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation